-
Strides are being made in development of multipurpose prevention technologies, defined as a single product or strategy configured for at least two sexual and reproductive health prevention indications: unintended pregnancy, HIV, and other sexually transmitted infections.
-
-
Labeling for the European levonorgestrel (LNG) emergency contraceptive pill NorLevo has been revised due to data indicating lower drug efficacy in women weighing 165 pounds and above. This move has led U.S. regulators to assess data on similar products.
-
The Bill & Melinda Gates Foundation has just released funding to support 11 projects that aim to improve uptake and regular use of male and female condoms by developing new designs that significantly preserve or enhance pleasure and simplify use.
-
-
-
A review of 10 years of national data indicates that clinicians have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women: those who have undergone hysterectomies and those older than age 65 with no cervical cancer history.
-
This special feature will summarize FDA position statements pertaining to mesh use in obstetrics and gynecology....
-
An inebriated frequent emergency department (ED) patient, discharged after a cursory examination and no treatment, was found dead in the hospital's parking lot a few hours later.
-
Two years ago, a Texas court, in the case of Dr. Zawislak v. Memorial Hermann Hospital, determined that emergency physicians were "employees" of the hospital for determining whether they could sue the hospital under the Emergency Medical Treatment and Labor Act's (EMTALA) whistleblower provision for retaliatory termination (see the February 2012 ED Legal Letter).